Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Showing 20 of 0 results

Very early researchUnknownNCT03537482
What this trial is testing

APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Ascentage Pharma Group Inc. 90
Testing effectiveness (Phase 2)Study completedNCT00322023
What this trial is testing

Safety and Effectiveness of D-serine in Schizophrenia

Who this might be right for
Schizophrenia
Nathan Kline Institute for Psychiatric Research 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT07471880
What this trial is testing

A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head

Who this might be right for
OsteonecrosisOsteonecrosis of the Femoral Head
ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. 161
Testing effectiveness (Phase 2)Study completedNCT01407003
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Novartis Pharmaceuticals 138
Early research (Phase 1)Ended earlyNCT06961370
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Geographic AtrophyAge-related Macular Degeneration
Hoffmann-La Roche 27
Early research (Phase 1)Study completedNCT03282851
What this trial is testing

Pharmacokinetics/Pharmacodynamics (PK/PD) Equivalence Study of MSB11456

Who this might be right for
Healthy
Fresenius Kabi SwissBioSim GmbH 696
Testing effectiveness (Phase 2)Study completedNCT01965509
What this trial is testing

A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT00617994
What this trial is testing

Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis

Who this might be right for
Psoriasis
Incyte Corporation 25
Early research (Phase 1)UnknownNCT02366351
What this trial is testing

The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Type 2 Diabetes Mellitus Patients

Who this might be right for
Type 2 Diabetes Mellitus
Jiangsu HengRui Medicine Co., Ltd. 168
Early research (Phase 1)Study completedNCT06678581
What this trial is testing

SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese Subjects

Who this might be right for
GoutHyperuricemia
Shanton Pharma Co., Ltd. 70
Early research (Phase 1)Study completedNCT03762772
What this trial is testing

Safety, PK, and PD Study of a Vaginal Insert Containing TAF and EVG

Who this might be right for
HivHSV
CONRAD 16
Testing effectiveness (Phase 2)Study completedNCT01083732
What this trial is testing

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 18
Early research (Phase 1)WithdrawnNCT02667535
What this trial is testing

PK, PD and Safety Comparative Trial of Isosorbide Mononitrate Gel in Healthy Participants and With Anal Fissure

Who this might be right for
Anal Fissure
Biolab Sanus Farmaceutica
Early research (Phase 1)Looking for participantsNCT07283796
What this trial is testing

Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
NHL
Haisco Pharmaceutical Group Co., Ltd. 110
Early research (Phase 1)Study completedNCT05756920
What this trial is testing

This is a Study to Evaluate the Safety, Tolerability, PK and PD of IV Administered ABL301 in Healthy Adult Participants

Who this might be right for
Healthy
ABL Bio, Inc. 91
Testing effectiveness (Phase 2)Ended earlyNCT05574010
What this trial is testing

Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it)

Who this might be right for
Celiac Disease
Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA 128
Early research (Phase 1)Ended earlyNCT01808482
What this trial is testing

A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT05428696
What this trial is testing

Safety and Tolerability, PK, and PD Study of Single and Multiple ALXN2080 Doses in Healthy Participants

Who this might be right for
Healthy
Alexion Pharmaceuticals, Inc. 90
Early research (Phase 1)Looking for participantsNCT06809114
What this trial is testing

FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Axcynsis Therapeutics Pte Ltd 83
Large-scale testing (Phase 3)Study completedNCT01625390
What this trial is testing

A Phase 2/ 3 Trial to Evaluate the Efficacy and Safety of BAY86-6150

Who this might be right for
Hemophilia A, Hemophilia B
Bayer 10
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation